Modelling erythropoiesis through disease: rare inherited anaemias and the differentiation of laboratory-generated red cells

Red blood cells (RBCs) are produced across gestation and early life through three sequential waves: primitive, intermediate and definitive, each arising from distinct progenitor populations and occurring at different anatomical sites. Rare inherited anaemias (RIAs) can occur when genetic mutations disrupt the differentiation, maturation or survival of erythroblasts. Because these waves are temporally and spatially segregated, the gestational timing and severity of fetal anaemia can inform both the stage of development where a pathway is required and the stage in which erythropoiesis is disrupted. In this review, we discuss prenatal clinical evaluation and diagnostic pathways for suspected fetal anaemias, including clinical burden and limitations of current management (i.e., transfusion dependence, alloimmunisation and iron overload), in combination with discussion of the genetic and pathway level causes of RIAs. We evaluate the observed defective erythropoiesis (i.e., reduced erythroid output due to impaired progenitor commitment, proliferation or early differentiation) or ineffective erythropoiesis (terminal maturation failure) in RIAs and link these to the common failures observed in vitro stem cell-derived systems. As RIAs can be used to identify pathway checkpoints that when perturbed reduce effective erythroid output in the natural setting, we discuss the importance of disease-informed modelling to inform developmental benchmarks and readouts for laboratory-generated RBCs and support emerging fetal therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-17
DOI
https://doi.org/10.3389/fcell.2026.1967904
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Modelling erythropoiesis through disease: rare inherited anaemias and the differentiation of laboratory-generated red cells

Ivan Alić, Nur Syazana Roslan, Karen Mei Xian Lim, Mahesh Choolani et al.
1 links
Frontiers in Cell and Developmental Biology
Hematopoietic Stem Cell Transplantation
article

Modelling erythropoiesis through disease: rare inherited anaemias and the differentiation of laboratory-generated red cells

Ivan Alić, Nur Syazana Roslan, Karen Mei Xian Lim, Mahesh Choolani, Gillian Gough, Aniza Puteri Mahyuddin, Sreenidhi Senthilkumar, Gordon S. T. Ng
article en

Abstract

Red blood cells (RBCs) are produced across gestation and early life through three sequential waves: primitive, intermediate and definitive, each arising from distinct progenitor populations and occurring at different anatomical sites. Rare inherited anaemias (RIAs) can occur when genetic mutations disrupt the differentiation, maturation or survival of erythroblasts. Because these waves are temporally and spatially segregated, the gestational timing and severity of fetal anaemia can inform both the stage of development where a pathway is required and the stage in which erythropoiesis is disrupted. In this review, we discuss prenatal clinical evaluation and diagnostic pathways for suspected fetal anaemias, including clinical burden and limitations of current management (i.e., transfusion dependence, alloimmunisation and iron overload), in combination with discussion of the genetic and pathway level causes of RIAs. We evaluate the observed defective erythropoiesis (i.e., reduced erythroid output due to impaired progenitor commitment, proliferation or early differentiation) or ineffective erythropoiesis (terminal maturation failure) in RIAs and link these to the common failures observed in vitro stem cell-derived systems. As RIAs can be used to identify pathway checkpoints that when perturbed reduce effective erythroid output in the natural setting, we discuss the importance of disease-informed modelling to inform developmental benchmarks and readouts for laboratory-generated RBCs and support emerging fetal therapeutic strategies.

Frontiers in Cell and Developmental BiologyVol. 14
National University of Singapore (SG), University of Zagreb (HR), National University Hospital (SG), National University Health System (SG)
National Medical Research Council
Good health and well-being
Hematopoietic Stem Cell Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon